Genetic variation among parthenogenetic Meloidogyne species revealed by AFLPs and 2D-protein electrophoresis contrasted to morphology

Des isolats appartenant aux espèces parthénogénétiques améiotiques #Meloidogyne arenaria, #M. hapla race B, #M. incognita, #M. javanica et parthénogénéiques méiotiques #M. chitwoodi, #M. fallax, #M. hapla race A, #M. naasi ont été comparés quant à leurs protéines totales solubles - par électrophorèse sur gel en deux dimensions (2-DGE) -, leur ADN génomique total - par AFLP - et leurs caractères morphologiques - par mensurations directes et données provenant de la littérature. Ces données ont été transformées en coefficients de similarité en utilisant le coefficient Dice basé sur plus de 100 spots protéiniques, 192 fragments d'AFLP et 21 caractères morphologiques. Les dendogrammes, établis suivant la méthode UPGMA basés sur les données fournies par les protéines et l'ADN sont congruents. Le groupement des races A et B de #M. hapla montre une similarité élevée, les trois espèces tropicales #M. incognita, M. javanica et #M. arenaria forment un autre groupe et les espèces spécialisées envers les graminées, #M. naasi, #M. chitwoodi; #M. fallax, sont distantes des autres, les deux dernières montrant une similarité élevée. Le dendogramme basé sur les données morphologiques diffère de ceux basés sur les données moléculaires, notamment pour #M. incognita et #M. naasi$. Il est discuté de cette non correspondance entre données provenant des protéines et de l'ADN, d'une part, et données morphologiques, d'autre part. (Résumé d'auteur

Indoleamine-2,3-dioxygenase activity in experimental human endotoxemia

Background: Excessive tryptophan metabolism to kynurenine by the rate-limiting enzyme endothelial indoleamine 2,3-dioxygenase 1 (IDO) controls arterial vessel relaxation and causes hypotension in murine endotoxemia. However, its relevance in human endotoxemia has not been investigated so far. We thus aimed to study changes in blood pressure in parallel with tryptophan and kynurenine levels during experimental endotoxemia in humans. Findings: Six healthy male volunteers were given E. coli lipopolysaccharide (LPS; 4 ng/kg) as a 1-min intravenous infusion. They had levels of soluble E-Selectin and soluble vascular cell adhesion molecule-1 as well as IDO activity assessed as the kynurenine-to-tryptophan plasma ratio by liquid chromatography-tandem mass spectrometry at various time points during a 24 h time course. During endotoxemia, IDO activity significantly increased, reaching peak levels at 8 h after LPS infusion (44.0 ± 15.2 vs. 29.4 ± 6.8 at baseline, P<0.0001). IDO activity correlated inversely with the development of hypotension as shown by random effects linear regression models. Finally, IDO activity exhibited a kinetic profile similar to that of soluble endothelial-specific adhesion molecules. Conclusions: LPS is a triggering factor for the induction of IDO in men. Our findings strongly support the concept that the induction of IDO in the vascular endothelium contributes to hypotension in human sepsis

Dynamical parton distributions of the nucleon and very small-x physics

Utilizing recent DIS measurements (F_{2,L}) and data on dilepton and high-E_{T} jet production we determine the dynamical parton distributions of the nucleon generated radiatively from valence-like positive input distributions at optimally chosen low resolution scales. These are compared with `standard' distributions generated from positive input distributions at some fixed and higher resolution scale. It is shown that up to the next to leading order NLO(\bar{MS}, DIS) of perturbative QCD considered in this paper, the uncertainties of the dynamical distributions are, as expected, smaller than those of their standard counterparts. This holds true in particular in the presently unexplored extremely small-x region relevant for evaluating ultrahigh energy cross sections in astrophysical applications. It is noted that our new dynamical distributions are compatible, within the presently determined uncertainties, with previously determined dynamical parton distributions.Comment: 21 pages, 2 tables, 16 figures, v2: added Ref.[60], replaced Fig.

Pneumocystis Pneumonia in HIV-positive Adults, Malawi1

In a prospective study of 660 HIV-positive Malawian adults, we diagnosed Pneumocystis jirovecii pneumonia (PcP) using clinical features, induced sputum for immunofluorescent staining, real-time PCR, and posttreatment follow-up. PcP incidence was highest in patients with the lowest CD4 counts but uncommon compared with incidences of pulmonary tuberculosis and bacterial pneumonia

an overview of the MHONGOOSE survey: Observing nearby galaxies with MeerKAT

© Copyright owned by the author(s). MHONGOOSE is a deep survey of the neutral hydrogen distribution in a representative sample of 30 nearby disk and dwarf galaxies with H I masses from ∼ 106 to ∼ 1011 M, and luminosities from MR ∼ 12 to MR ∼ −22. The sample is selected to uniformly cover the available range in log(MHI). Our extremely deep observations, down to H I column density limits of well below 1018 cm−2 — or a few hundred times fainter than the typical H I disks in galaxies — will directly detect the effects of cold accretion from the intergalactic medium and the links with the cosmic web. These observations will be the first ever to probe the very low-column density neutral gas in galaxies at these high resolutions. Combination with data at other wavelengths, most of it already available, will enable accurate modeling of the properties and evolution of the mass components in these galaxies and link these with the effects of environment, dark matter distribution, and other fundamental properties such as halo mass and angular momentum. MHONGOOSE can already start addressing some of the SKA-1 science goals and will provide a comprehensive inventory of the processes driving the transformation and evolution of galaxies in the nearby universe at high resolution and over 5 orders of magnitude in column density. It will be a Nearby Galaxies Legacy Survey that will be unsurpassed until the advent of the SKA, and can serve as a highly visible, lasting statement of MeerKAT’s capabilities

Outcome in patients perceived as receiving excessive care across different ethical climates: a prospective study in 68 intensive care units in Europe and the USA

Purpose: Whether the quality of the ethical climate in the intensive care unit (ICU) improves the identification of patients receiving excessive care and affects patient outcomes is unknown. Methods: In this prospective observational study, perceptions of excessive care (PECs) by clinicians working in 68 ICUs in Europe and the USA were collected daily during a 28-day period. The quality of the ethical climate in the ICUs was assessed via a validated questionnaire. We compared the combined endpoint (death, not at home or poor quality of life at 1 year) of patients with PECs and the time from PECs until written treatment-limitation decisions (TLDs) and death across the four climates defined via cluster analysis. Results: Of the 4747 eligible clinicians, 2992 (63%) evaluated the ethical climate in their ICU. Of the 321 and 623 patients not admitted for monitoring only in ICUs with a good (n = 12, 18%) and poor (n = 24, 35%) climate, 36 (11%) and 74 (12%), respectively were identified with PECs by at least two clinicians. Of the 35 and 71 identified patients with an available combined endpoint, 100% (95% CI 90.0–1.00) and 85.9% (75.4–92.0) (P = 0.02) attained that endpoint. The risk of death (HR 1.88, 95% CI 1.20–2.92) or receiving a written TLD (HR 2.32, CI 1.11–4.85) in patients with PECs by at least two clinicians was higher in ICUs with a good climate than in those with a poor one. The differences between ICUs with an average climate, with (n = 12, 18%) or without (n = 20, 29%) nursing involvement at the end of life, and ICUs with a poor climate were less obvious but still in favour of the former. Conclusion: Enhancing the quality of the ethical climate in the ICU may improve both the identification of patients receiving excessive care and the decision-making process at the end of life